Yongqing Chen is the founder of GX Pharma. GX Pharma has raised $60M in total funding. Based in Beijing, China.
Yongqing Chen, also known as Tony Chen, is the Founder and Chief Executive Officer of Phrontline Biopharma, a company established in 2022. Phrontline Biopharma focuses on next-generation antibody-drug conjugates (ADCs), specifically bispecific and dual-payload ADCs, and has developed an end-to-end ADC platform. The company recently closed a $60 million Pre-A+ financing round.
Full founder directory · Investor directory · Company funding database · Fundraising library